Rheumatoid Arthritis
Conditions
Brief summary
This study will assess the feasibility of using cytokine expression profiles in blood samples as a method for evaluating rheumatoid polyarthritis
Interventions
PROCEDUREBlood sample
2ml blood taken into TruCulture tube
Sponsors
Centre Hospitalier Universitaire de Nīmes
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Patient is at least 18 years old * Subjects included as patients have rheumatoid polyarthritis according to ACR EULA 2010, DAS28\>3.2 criteria * Subjects included as controls are healthy volunteers who have no overexpression of cytokines
Exclusion criteria
* The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient has had at least 3 months of specific treatment that can potentially impact cytokine profile
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dosage of cytokines between groups | Day 0 | Concentration measured by ELISA and flow cytometry |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Creation of biobank | Day 0 | Storage of blood samples |
Countries
France
Outcome results
None listed